Pilot Study using Neoadjuvant Chemoradiotherapy and EGFR-Tyrosine Kinase Inhibitor for Potentially Resectable Pancreatic Cancer
2011 ◽
Vol 81
(2)
◽
pp. S343
2011 ◽
Vol 10
(6)
◽
pp. 1102-1112
◽
2018 ◽
Vol 15
(8)
◽
pp. 3216-3226
◽